Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy
about
Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the humanIntegration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.The role of GATA2 in lethal prostate cancer aggressiveness.Proteomic analysis of urinary upper gastrointestinal cancer markers.The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease.Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population.Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer.The role of the basal stem cell of the human breast in normal development and cancer.Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations.Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosisLarge isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.Markers for detection of prostate cancer.Using molecular markers to help predict who will fail after radical prostatectomy.The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.Evaluation of Serum Zinc Level Under Malignant Condition and its Possible Implication on Improving Cell-Mediated Immunity During Cancer Progression.AZGP1 inhibits soft tissue sarcoma cells invasion and migration.A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer.Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer.INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity.[cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer].
P2860
Q24648354-CB0A7FBD-C1CD-4840-8E22-2D71332BA3BDQ31111254-916250C0-75DD-441E-9C57-F78D9803B253Q33609420-31DCC283-4C39-46E8-88B3-CD513AC46ECFQ33697764-E4D4FA42-E5ED-4613-AFBC-9B58C6A0F2ECQ33768593-D868BA95-D455-49F9-94AA-E816D8C0862DQ33848134-B55B3E32-23BB-4498-947B-5BED73434D2FQ33888474-0F6519B5-AC51-403E-9085-AFB673B85939Q34403242-6A656088-D16A-42BC-AD2B-095A305F2E13Q34484407-6CE19E33-8C58-4923-AF20-66E4A313CBCFQ34998516-F4B1F688-1328-4714-913E-B4722BFAF9FDQ35016495-E68B8D6F-D70D-474A-A7D8-EC1AF0ED4E8FQ35313220-DD0A848D-4AB0-4824-A23F-B23ED83AC4B4Q35669146-D6E5E8A6-C520-4838-84CD-E74B0B3C5B81Q36326652-33C76880-552F-48DF-8CED-F084097E9EF9Q36334864-630A0574-6F09-48E0-9382-69F958B557C8Q36678643-B1D39C24-91E8-46CA-9818-983BF2279DD7Q36915415-158B96DB-0EF2-41FD-938D-8ED8C9127B11Q37328403-C4246960-62EB-4B0F-8338-B966B584C52CQ37957896-E427659D-8504-4494-8B58-8437F655657CQ38063121-8D899D3A-1CBD-49E6-8C15-A62EF26FB0E6Q38384375-7157C6C5-ADC7-4EC7-9A69-140294AABDCEQ39545306-0B89D900-8CFE-4BBD-8526-D2031EB1F7C8Q40526157-74067729-E7F6-4999-B77F-D7EF7A4B46A9Q42660306-44C56468-829B-4B7E-AD99-B1D48249BA6AQ42845103-D30B11A4-A947-4698-8F8B-23D6DC39AD03Q45874570-87AB007B-F268-4C2B-8208-D371D4CDA2F9Q48192538-B11C462C-2E3E-4F06-BB9F-623CB991F70BQ50660769-FA9D9953-FE91-482C-8E5D-CFC17CD3A982Q51250068-48CB7B8D-F973-45A1-9132-396220308C0AQ51606266-B65BF415-5FE9-4E02-BE9B-59EDA4736AB9Q54317525-EA635CBA-10FE-44B8-9FB6-87BED3229B73Q54962725-B82048ED-262F-40E5-802A-FF1BBBDCAB53Q55048709-0CAB1A76-EFDF-490C-8FBB-C78E00BB5BC5Q55438202-E58366F6-59B1-4B1D-ABFA-24D6CD353983
P2860
Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy
description
article
@en
im Oktober 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2006
@uk
name
Zinc-alpha2-glycoprotein Expre ...... ollowing Radical Prostatectomy
@en
Zinc-alpha2-glycoprotein Expre ...... ollowing Radical Prostatectomy
@nl
type
label
Zinc-alpha2-glycoprotein Expre ...... ollowing Radical Prostatectomy
@en
Zinc-alpha2-glycoprotein Expre ...... ollowing Radical Prostatectomy
@nl
prefLabel
Zinc-alpha2-glycoprotein Expre ...... ollowing Radical Prostatectomy
@en
Zinc-alpha2-glycoprotein Expre ...... ollowing Radical Prostatectomy
@nl
P2093
P50
P356
P1476
Zinc-alpha2-glycoprotein expre ...... ollowing radical prostatectomy
@en
P2093
John J Grygiel
Robert L Sutherland
Sarah A Eggleton
Susan M Henshall
P304
P356
10.1093/JNCI/DJJ378
P407
P577
2006-10-01T00:00:00Z